while the 36-month beta value is 0.98.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price point forecasted by analysts for Zomedica Corp. (ZOM) is $6.00, which is $5.77 above the current market price. The public float for ZOM is 965.42M, and currently, short sellers hold a 8.61% ratio of that floaft. The average trading volume of ZOM on March 17, 2023 was 9.61M shares.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
ZOM) stock’s latest price update
Zomedica Corp. (AMEX: ZOM)’s stock price has decreased by -3.08 compared to its previous closing price of 0.24. however, the company has experienced a -8.32% decrease in its stock price over the last five trading days.
ZOM’s Market Performance
Zomedica Corp. (ZOM) has seen a -8.32% fall in stock performance for the week, with a -12.79% decline in the past month and a 18.43% surge in the past quarter. The volatility ratio for the week is 9.53%, and the volatility levels for the past 30 days are at 6.23% for ZOM. The simple moving average for the last 20 days is -6.06% for ZOM stock, with a simple moving average of -3.43% for the last 200 days.
Analysts’ Opinion of ZOM
Many brokerage firms have already submitted their reports for ZOM stocks, with Dawson James repeating the rating for ZOM by listing it as a “Buy.” The predicted price for ZOM in the upcoming period, according to Dawson James is $6 based on the research report published on January 06th of the current year 2023.
ZOM Trading at -8.25% from the 50-Day Moving Average
After a stumble in the market that brought ZOM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.27% of loss for the given period.
Volatility was left at 6.23%, however, over the last 30 days, the volatility rate increased by 9.53%, as shares sank -14.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +45.01% upper at present.
During the last 5 trading sessions, ZOM fell by -8.32%, which changed the moving average for the period of 200-days by -1.23% in comparison to the 20-day moving average, which settled at $0.2457. In addition, Zomedica Corp. saw 42.70% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ZOM
Current profitability levels for the company are sitting at:
- -517.14 for the present operating margin
- +46.32 for the gross margin
The net margin for Zomedica Corp. stands at -444.78. Equity return is now at value -6.50, with -6.30 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 46.18.
Conclusion
In a nutshell, Zomedica Corp. (ZOM) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
